Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study - Takeaways - MDSpire

Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study

  • By

  • Tiphaine Obara

  • Marie Blonski

  • Marie Forest-Dodelin

  • Fabien Rech

  • Luc Taillandier

  • December 16, 2024

  • 0 min

Share

  • 1

    Diffuse low-grade gliomas are slow-growing brain tumors that can progress to high-grade gliomas, impacting patient survival and quality of life.

  • 2

    Health-related quality of life (HRQoL) in LGG patients is affected by cognitive and emotional dysfunction, fatigue, anxiety, and depression.

  • 3

    The study assessed HRQoL in 62 LGG patients during a non-therapeutic phase, comparing their self-assessments to a normative population.

  • 4

    Factors influencing HRQoL include tumor characteristics, treatment effects, psychological status, and socio-economic conditions.

  • 5

    The research highlights the need for long-term HRQoL studies in LGG patients, particularly during non-therapeutic periods.

Original Source(s)

Health-related quality of life in 62 patients with diffuse low-grade glioma during a non-therapeutic and progression-free phase: a cross-sectional study

  • by Tiphaine Obara, Marie Blonski, Marie Forest-Dodelin, Fabien Rech, Luc Taillandier

  • December 16, 2024

Related Content

Holistic care in inflammatory bowel disease: is it in REACH?

Evaluating the psychosocial effects of cancer on sleep quality and mental health in elderly populations

Risk prediction models for depression in older adults with cancer